D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 72 Citations 23,601 263 World Ranking 14275 National Ranking 7384

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

His primary areas of investigation include Internal medicine, Immunology, Oncology, Gastroenterology and Cancer. His Internal medicine study combines topics in areas such as Surgery and Immune system. His Immunology research is multidisciplinary, incorporating perspectives in Diphtheria toxin, Chemotherapy and Sarcoma.

His Oncology research is multidisciplinary, incorporating elements of Pcr cloning, Breast surgery, Treatment outcome, Lymph node and Bevacizumab. In general Cancer, his work in Breast disease is often linked to Mechanism linking many areas of study. His Breast cancer study integrates concerns from other disciplines, such as MEDLINE and Circulating tumor cell.

His most cited work include:

  • Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer (3458 citations)
  • Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer (892 citations)
  • Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia (739 citations)

What are the main themes of his work throughout his whole career to date?

James M. Reuben mainly investigates Internal medicine, Immunology, Breast cancer, Oncology and Cancer. His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Surgery. His Gastroenterology research incorporates themes from Chronic lymphocytic leukemia, Toxicity and Lenalidomide.

James M. Reuben combines subjects such as Cancer research, Metastasis, Circulating tumor cell and Pathology with his study of Breast cancer. James M. Reuben studied Circulating tumor cell and Metastatic breast cancer that intersect with Survival analysis. His work carried out in the field of Oncology brings together such families of science as Stage, Triple-negative breast cancer and Clinical trial, Phases of clinical research.

He most often published in these fields:

  • Internal medicine (43.60%)
  • Immunology (38.37%)
  • Breast cancer (29.07%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (43.60%)
  • Breast cancer (29.07%)
  • Oncology (27.33%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Breast cancer, Oncology, Cancer research and Cancer. His study focuses on the intersection of Internal medicine and fields such as Immunology with connections in the field of Gastroenterology. His Breast cancer research includes elements of Metastasis and Disease, Pathology.

His work on Surgical oncology as part of general Oncology study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His work deals with themes such as Circulating tumor cell, Cancer cell, Cancer stem cell, CD8 and Primary breast cancer, which intersect with Cancer research. In his study, Definitive radiotherapy and Radiation therapy is inextricably linked to Lung cancer, which falls within the broad field of Cancer.

Between 2015 and 2021, his most popular works were:

  • The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper (79 citations)
  • Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2–Negative Metastatic Breast Cancer (78 citations)
  • Inflammatory breast cancer biology: the tumour microenvironment is key (74 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

James M. Reuben spends much of his time researching Breast cancer, Cancer research, Inflammatory breast cancer, Internal medicine and Oncology. His work on Disease expands to the thematically related Breast cancer. His Cancer research research integrates issues from Cancer cell, Cancer, CD8 and Circulating tumor cell.

His Internal medicine research is multidisciplinary, incorporating perspectives in Protein expression and Gerontology. His Oncology study incorporates themes from Stage, Triple-negative breast cancer, Chemotherapy and Clinical trial. As a member of one scientific family, James M. Reuben mostly works in the field of Triple-negative breast cancer, focusing on Immunology and, on occasion, Gastroenterology, Regimen and Tolerability.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Massimo Cristofanilli;G. Thomas Budd;Matthew J. Ellis;Alison Stopeck.
The New England Journal of Medicine (2004)

4519 Citations

Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

Massimo Cristofanilli;Daniel F. Hayes;G. Thomas Budd;Mathew J. Ellis.
Journal of Clinical Oncology (2005)

1209 Citations

Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

Jorge R. Quesada;James M Reuben;John T. Manning;Evan M. Hersh.
The New England Journal of Medicine (1984)

957 Citations

Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

Elise Olsen;Madeleine Duvic;Arthur Frankel;Youn Kim.
Journal of Clinical Oncology (2001)

732 Citations

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Antoni Ribas;Luis H. Camacho;Gabriel Lopez-Berestein;Dmitri Pavlov.
Journal of Clinical Oncology (2005)

633 Citations

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms

Charles S. Cleeland;Gary J. Bennett;Robert Dantzer;Patrick M. Dougherty.
Cancer (2003)

585 Citations

Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

Gabriel Lopez-Berestein;Victor Fainstein;Roy Hopfer;Kapil Mehta.
The Journal of Infectious Diseases (1985)

517 Citations

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia.

Alessandra Ferrajoli;Bang-Ning Lee;Ellen J. Schlette;Susan M. O'Brien.
Blood (2008)

506 Citations

Soluble TNF-α receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight

William T. Shearer;James M. Reuben;Janet M. Mullington;Nicholas J. Price.
The Journal of Allergy and Clinical Immunology (2001)

472 Citations

Nuclear factor–κB and STAT3 are constitutively active in CD138+cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

Alok C. Bharti;Shishir Shishodia;James M. Reuben;Donna Weber.
Blood (2004)

386 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing James M. Reuben

Klaus Pantel

Klaus Pantel

Universität Hamburg

Publications: 133

Massimo Cristofanilli

Massimo Cristofanilli

Northwestern University

Publications: 111

Madeleine Duvic

Madeleine Duvic

The University of Texas MD Anderson Cancer Center

Publications: 54

Leon W.M.M. Terstappen

Leon W.M.M. Terstappen

University of Twente

Publications: 48

Razelle Kurzrock

Razelle Kurzrock

Medical College of Wisconsin

Publications: 44

Daniel F. Hayes

Daniel F. Hayes

University of Michigan–Ann Arbor

Publications: 41

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 38

John C. Byrd

John C. Byrd

University of Cincinnati

Publications: 37

Johann S. de Bono

Johann S. de Bono

Institute of Cancer Research

Publications: 36

Chwee Teck Lim

Chwee Teck Lim

National University of Singapore

Publications: 36

Michael J. Keating

Michael J. Keating

The University of Texas MD Anderson Cancer Center

Publications: 36

Susan O'Brien

Susan O'Brien

University of California, Irvine

Publications: 33

Richard J. Cote

Richard J. Cote

University of Miami

Publications: 31

Harvey M. Golomb

Harvey M. Golomb

University of Chicago

Publications: 31

Tadeusz Robak

Tadeusz Robak

Medical University of Lodz

Publications: 29

Michael R. Irwin

Michael R. Irwin

University of California, Los Angeles

Publications: 29

Something went wrong. Please try again later.